Skip to main navigation
Logo

Live - Corprorate Menu

  • About Us
    • Our Leadership
    • Diversity, Equity, and Inclusion
    • Collaborations
    • Compliance and Ethics
    • Corporate Giving
  • Our Focus
    • Cerebral Adrenoleukodystrophy
    • Sickle Cell Disease
    • Transfusion Dependant Beta-Thalassemia
  • Our Science
    • Our Approach to Gene Therapy
    • Our Treatment Process
    • Our Pipeline
    • Clinical Trials
  • Our Therapies
  • Patients & Advocacy
    • Patient Advocacy
    • Patient Resources
    • Access Policy

Live - Top Nav

  • investors & media
  • contact us
  • careers

Investors & Media

Overview Corporate Governance Press Releases Events & Presentations Analyst Coverage Stock Information SEC Filings Investor FAQs

Toolkit

  • Annual Meeting
  • Information Request
  • Sign Up for Email Alerts
  • RSS Feeds

Media Contacts

  • Jess Rowlands

    Head of Corporate Communications

    (857) 299-6103

    jess.rowlands@bluebirdbio.com

Investor Contacts

  • Courtney O’Leary

    Investor Relations

    (978) 621-7347

    coleary@bluebirdbio.com

events & presentations

Corporate Presentation - January 2023 6.6 MB

upcoming events

There are currently no events to display.
past events
Date Title
Jan 12, 2023 at 7:30 AM PST
41st Annual J.P. Morgan Healthcare Conference
Nov 8, 2022 at 5:00 PM PST
31st Annual Credit Suisse Healthcare Conference
Sep 19, 2022 at 8:00 AM EDT
SKYSONA® Launch Call
Sep 13, 2022 at 8:35 AM EDT
Morgan Stanley 20th Annual Global Healthcare Conference
Sep 8, 2022 at 9:10 AM EDT
2022 Wells Fargo Healthcare Conference

Quick Links

  • Patients & Advocacy
  • Investors & Media
  • Careers
  • Contact Us

CONTACT INFO

info@bluebirdbio.com

clinicaltrials@bluebirdbio.com

investor@bluebirdbio.com

medinfo@bluebirdbio.com

Live - Terms & Privacy

  • Terms of Service
  • Privacy Policy
  • Cookie Notice
  • Sitemap
© 2023 bluebird bio, Inc. All Rights Reserved. Corp-US-00175 04/22

Live - Social Links